Sign In
Buy GEHC
$68.02
-1.92 (-2.75%)
At Close: Jul 31, 2026
I'm excited for what Alzheimer's drugs will do for patients, says GE Healthcare CEO Peter Arduini
08:08pm, Tuesday, 25'th Jul 2023
GE Healthcare President and CEO Peter Arduini goes one-on-one with 'Mad Money' host Jim Cramer to talk the spinoff from GE and what the past year has been like for the company.
A Surprising Beneficiary of New Alzheimer's Drugs: GE HealthCare
11:41am, Tuesday, 25'th Jul 2023
Biogen, Eli Lilly drugs will expand the imaging market for companies in the diagnostics space.
GE HealthCare raises 2023 profit forecast as supply chain woes ease
08:07am, Tuesday, 25'th Jul 2023
GE HealthCare Technologies Inc raised its annual profit forecast on Tuesday, after beating quarterly earnings estimates due to easing supply chain issues that had largely impacted electronic component
GE HealthCare earnings fell from a year ago but top estimates
06:33am, Tuesday, 25'th Jul 2023
GE HealthCare Technologies Inc. GEHC, -2.42% beat consensus estimates for the second quarter and raised its full-year guidance. The company, which was spun out of General Electric Co. in January, post
Want to Beat the Market Over the Next 10 Years? Consider These 3 Stocks
05:45am, Tuesday, 25'th Jul 2023
GE Healthcare has been unleashed and is now ready to increase its growth rate. LanzaTech is a leader in capturing carbon emissions and converting them to fuels and chemicals.
GE HealthCare (GEHC) to Report Q2 Earnings: What's in Store?
12:57pm, Friday, 21'st Jul 2023
GE HealthCare's (GEHC) Imaging revenue growth in Q2 is expected to have been led by Magnetic Resonance as well as its molecular imaging entity.
3 Healthcare Stocks Using AI to Deliver You Healthy Profits
05:36pm, Tuesday, 18'th Jul 2023
Artificial intelligence ( AI ) is aiming to revolutionize the healthcare sector, forging a new era of medical innovation. As we dive into the realm of the top AI healthcare stocks, it's imperative to
Want to Get Richer? 3 High-Flying Stocks to Buy Now
05:06am, Saturday, 15'th Jul 2023
This dividend investor's favorite looks like a good value for long-term investors. A healthcare stock with a long runway of growth ahead of it.
Spinoffs Roundup: These Companies Could Unlock Value in 2023
03:53pm, Wednesday, 05'th Jul 2023
Spinoffs are known for being a mixed bag from an investor's viewpoint. Some of them can unlock the true value of businesses by allowing the spinoff and the parent company to focus on their niches rath
GE HealthCare to Announce Second Quarter 2023 Results on July 25, 2023
08:49am, Thursday, 29'th Jun 2023
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, will announce its second quarter 2023 financial results before the market opens on Tuesday, July 25, 2023
GE HealthCare: A Good Future Dividend Growth Stock?
07:30am, Thursday, 29'th Jun 2023
GE HealthCare Technologies, a spin-off from General Electric, is performing well with a market cap of around $35 billion and strong tailwinds in the healthcare industry. The company operates in four b
2 Stocks That Are Absurdly Cheap Right Now
10:27am, Wednesday, 21'st Jun 2023
The electrification of the economy and the clean energy revolution will be major drivers of copper demand, helping this copper miner. This healthcare company is set for profit margin recovery and long
GE HealthCare: Leading The Way In Transforming Healthcare
11:44pm, Monday, 19'th Jun 2023
GE Healthcare is a leading global medical technology and digital solutions company with significant growth potential, driven by macro trends such as precision health, digitization, and improved access
Why It's a Great Time to Buy GE HealthCare Stock
07:30am, Friday, 16'th Jun 2023
The spinoff from GE was likely met with some hesitancy from institutional buyers. GE HealthCare's valuation remains compelling despite its substantial rise this year.
Cramer says snap up this leading medtech stock — wishes he could buy shares too
03:36pm, Thursday, 08'th Jun 2023
GE Healthcare shares are sliding Thursday, creating a chance to buy this medical-technology company at an increasingly attractive valuation.
